Company research
AfterNext HealthTech Acquisition Corp.
CIK 1865975Updated Nov 16, 2026
Securities
AFTR price & chart
Historical security
This listing closed Aug 15, 2023. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2022 · USDSource
balance sheet · annual statements
| Line item | Q3 2022 | Q3 2021 | Q2 2023 | Q2 2022 | Q2 2021 | Q1 2023 | Q1 2022 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| AssetsUSD | 252,891,436Source | 252,791,317Source | 259,516,986Source | 252,097,940Source | 430,171Source | 256,945,844Source | 252,139,262Source | 254,624,832Source | 252,492,215Source |
| Current assets: | |||||||||
| Assets, CurrentUSD | 1,414,181Source | 2,791,317Source | 146,798Source | 1,750,978Source | — | 598,531Source | 2,139,262Source | 989,428Source | 2,492,215Source |
| LIABILITIES AND EQUITY | |||||||||
| LiabilitiesUSD | 13,041,105Source | 26,818,625Source | 11,956,415Source | 13,430,246Source | 448,945Source | 13,114,271Source | 16,465,190Source | 11,944,960Source | 20,039,610Source |
| Stockholders’ equity: | |||||||||
| Retained Earnings (Accumulated Deficit)USD | -11,627,549Source | -24,027,933Source | -11,810,242Source | -11,679,893Source | -43,774Source | -12,516,365Source | -14,326,553Source | -10,956,157Source | -17,548,020Source |
| Stockholders' Equity Attributable to ParentUSD | -11,626,924Source | -24,027,308Source | -11,809,617Source | -11,679,268Source | -18,774Source | -12,515,740Source | -14,325,928Source | -10,955,532Source | -17,547,395Source |
| Liabilities and EquityUSD | 252,891,436Source | 252,791,317Source | 259,516,986Source | 252,097,940Source | 430,171Source | 256,945,844Source | 252,139,262Source | 254,624,832Source | 252,492,215Source |
| Current liabilities: | |||||||||
| Liabilities, CurrentUSD | 13,041,105Source | 18,068,625Source | 11,956,415Source | 4,680,246Source | — | 13,114,271Source | 7,715,190Source | 11,944,960Source | 11,289,610Source |
| Additional Financial Items | |||||||||
| Accrued Liabilities, CurrentUSD | 211,105Source | — | 36,415Source | 210,246Source | — | 154,271Source | 255,190Source | 154,960Source | 189,610Source |
| Redeemable Noncontrolling Interest, Equity, Common, Carrying AmountUSD | 251,477,255Source | 250,000,000Source | 259,370,188Source | 250,346,962Source | — | 256,347,313Source | 250,000,000Source | 253,635,404Source | 250,000,000Source |
| Additional Paid in Capital, Common Stock | — | — | — | — | —Source | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2022 | Q3 2022 | Q3 2021 | Q2 2023 | Q2 2022 | Q2 2021 | Q1 2023 | Q1 2022 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -339,105Source | -215,456Source | -1,059,848Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | 25,000Source | -339,105Source | -215,456Source | -1,059,848Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | 937,075Source | 1,950,806Source | 21,183Source | 1,166,141Source | 25,000Source | 339,058Source | 1,522,555Source | 678,163Source |
| Additional Financial Items | |||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | 0Source | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Derivative, Gain (Loss) on Derivative, NetUSD | — | 390,000Source | 3,653,579Source | 1,040,000Source | 2,990,000Source | — | -1,170,000Source | 3,640,000Source | 8,060,000Source |
| Investment Income, InterestUSD | — | 1,130,293Source | — | 3,022,875Source | 346,962Source | — | 2,711,909Source | — | 3,635,404Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | 1,182,637Source | 2,679,618Source | 3,728,998Source | 2,993,622Source | -43,774Source | 1,151,701Source | 3,221,467Source | 10,227,267Source |
| Net Cash Provided by (Used in) Financing Activities | — | — | — | — | — | —Source | — | — | — |
| Proceeds from Issuance of Common Stock | — | — | — | — | — | —Source | — | — | — |
income statement · annual statements
| Line item | Q4 2022 | Q3 2022 | Q3 2021 | Q2 2023 | Q2 2022 | Q2 2021 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | — | — | — | —Source | — | — | — | — |
| Operating Income (Loss) | — | —Source | —Source | —Source | —Source | —Source | —Source | —Source |
| Investment Income, Interest | — | —Source | — | —Source | —Source | — | —Source | — |
| Net Income (Loss) Available to Common Stockholders, Basic | — | —Source | —Source | —Source | —Source | —Source | —Source | —Source |